Ditchcarbon
  • Contact
  1. Organizations
  2. ISU Abxis Co., Ltd.
Public Profile
Pharmaceutical Preparation Manufacturing
KR
updated 12 days ago

ISU Abxis Co., Ltd.

Company website

ISU Abxis Co., Ltd., a prominent player in the biotechnology sector, is headquartered in South Korea (KR) and operates extensively across Asia and beyond. Founded in 2004, the company has established itself as a leader in the development of innovative diagnostic solutions and therapeutic antibodies, catering to the growing demands of the healthcare industry. ISU Abxis is renowned for its cutting-edge products, including monoclonal antibodies and diagnostic kits, which are distinguished by their high specificity and reliability. The company’s commitment to research and development has led to significant advancements in immunology and molecular diagnostics, positioning it as a trusted partner in the global market. With a focus on quality and innovation, ISU Abxis continues to achieve notable milestones, solidifying its reputation as a key contributor to the biotechnology landscape.

DitchCarbon Score

How does ISU Abxis Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

22

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

ISU Abxis Co., Ltd.'s score of 22 is lower than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.

21%

Let us know if this data was useful to you

ISU Abxis Co., Ltd.'s reported carbon emissions

In 2021, ISU Abxis Co., Ltd., headquartered in South Korea, reported total carbon emissions of approximately 302,389,000 kg CO2e, which includes 246,930,200 kg CO2e from Scope 1 and 55,460,300 kg CO2e from Scope 2 emissions. This data reflects a slight increase from 2020, where emissions totalled about 280,812,000 kg CO2e, comprising 227,415,700 kg CO2e from Scope 1 and 53,397,700 kg CO2e from Scope 2. In 2019, the company reported total emissions of around 265,852,000 kg CO2e, with 214,133,100 kg CO2e from Scope 1 and 51,720,800 kg CO2e from Scope 2. ISU Abxis has not disclosed any specific reduction targets or initiatives, nor does it report on Scope 3 emissions. The company’s emissions data is not cascaded from a parent organisation, indicating that it operates independently in its reporting. The absence of climate pledges or SBTi targets suggests a need for further commitment to climate action within the industry context.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

201920202021
Scope 1
214,133,100
000,000,000
000,000,000
Scope 2
51,720,800
00,000,000
00,000,000
Scope 3
-
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. ISU Abxis Co., Ltd.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for ISU Abxis Co., Ltd. is in KR, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

ISU Abxis Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Chiesi Farmaceutici

IT
•
Pharmaceutical Preparation Manufacturing
Updated about 10 hours ago

Roche Holding AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Amgen

US
•
Pharmaceutical Preparation Manufacturing
Updated about 4 hours ago

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Gilead Sciences

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Sanofi

FR
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251007.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy